HOOK (HOOKIPA Pharma) Short-Term Debt to Capital
The financial stability of HOOKIPA Pharma Inc. (HOOK) depends on the support of key investors and research and development costs. The company's technological foundation relies on its own laboratories in the US and Austria, which collaborate with industry leaders. This price chart on GURU.Markets shows the 0.00 metric, supplementing data on the creation of innovative vaccines to combat dangerous infections and malignant tumors.
Analytical breakdowns for HOOKIPA Pharma Inc.
- stock quotes and analyst forecast:
- business market valuation indicators:
- book capitalization information:
- company liabilities and liquidity data:
Total Debt to Capital HOOKIPA Pharma Inc.|HOOK - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio HOOKIPA Pharma Inc.|HOOK - Aggregate Debt Obligations|Debts to Book Capitalization HOOKIPA Pharma, Inc.|HOOK - Long-Term Debt Volume|Company Short-Term Debt HOOKIPA Pharma|Quick Liquidity hookipapharma.com
- company profitability and valuation multiples indicators:
Fundamental valuation:HOOKIPA Pharma
HOOKIPA Pharma Inc. (HOOK) requires significant working capital to develop innovative immunotherapeutic drugs; therefore, this ratio, which measures the share of liabilities maturing within one year relative to equity, serves as an indicator of operational liquidity and financial stability. A decrease in this metric minimizes default risk but may signal a slowdown in expansion, making the trend of short-term loans relative to equity a key tool for assessing the company's readiness for product commercialization.
Main competitors
Short-Term Debt to Capital ARGX|BNTX (BioNTech Pharma) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital ABVX (Abivax Pharma)|Short-Term Debt to Capital admabiologics.com ADMA|PTGX - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital IMVT (Immunovant Inc)|Kiniksa Pharmaceuticals Ltd (KNSA) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio Grifols Biemat|ADPT (Adaptive Biotechnologies) - Short-Term Debt to Capital|Short-Term Debt to Capital celldex.com|Short-Term Debt to Equity Ratio AUPH (Aurinia Pharmaceuticals Inc.)|BCRX (BioCryst Pharmaceuticals, Inc.) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital VERA (Vera Pharma)|Short-Term Debt to Capital Coefficient Dianthus Corp (DNTH)|PHVS - Short-Term Debt to Equity|AbCellera Biologics Inc (ABCL) - Short-Term Debt to Equity Ratio|Tourmaline Bio (TRML) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio Precigen Inc|Short-Term Debt to Equity Ratio PHAR|Short-Term Debt to Capital Nektar Corp|Short-Term Debt to Equity Upstream Bio Inc (UPB)|zenasbio.com - Short-Term Debt to Capital Ratio|Short-Term Debt to Capital IMNM (Immunome)|Gossamer Bio Inc (GOSS) - Current Liabilities to Capital|KalVista Pharmaceuticals Inc - Short-Term Debt to Capital|Ratio of Short-Term Indebtedness to Capital SEPN (Septerna Pharma)|Pieris Pharmaceuticals (PVLA) - Short-Term Debt to Equity|Current Liabilities to Capital savarapharma.com (SVRA)|Short-Term Debt to Equity Rigel Pharmaceuticals, Inc.|Current Liabilities to Capital AnaptysBio Inc ANAB|Short-Term Debt to Equity Astria Pharma (ATXS)|Short-Term Debt to Capital enGene Corp (ENGN)|Short-Term Debt to Capital RAPT (RAPT Therapeutics)|Short-Term Debt to Capital Coefficient Aerovate Therapeutics, Inc. (JBIO)|ACRS - Short-Term Debt to Equity|Current Liabilities to Equity KYTX|TLSA: Short-Term Debt to Capital|Cabaletta Bio Inc (CABA) - Short-Term Debt to Capital|Short-Term Debt to Equity Ratio VTYX|THTX: Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity Avalo Therapeutics (AVTX)|ELDN: Current Liabilities to Equity|Short-Term Debt to Capital AGEN (Agenus Inc)|Ratio of Short-Term Indebtedness to Capital CLYM|Zura Bio - Short-Term Debt to Capital|ATYR - Short-Term Debt to Capital|adagene.com (ADAG) - Short-Term Debt to Equity|Ikena Oncology - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity Shattuck Labs Inc|Short-Term Debt to Equity Ratio Equillium Bio (EQ)|Short-Term Debt to Capital CNTB|Short-Term Debt to Capital immunic-therapeutics.com (IMUX)|Atara Bio - Short-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital IFRX|X4 Pharma - Short-Term Debt to Capital|Short-Term Debt to Capital Coefficient Adicet Bio ACET|celularity.com (CELU) - Short-Term Debt to Equity|Short-Term Debt to Capital Ratio INMB|BRNS (Barinthus Biotherapeutics plc) - Short-Term Debt to Capital|Short-Term Debt to Equity Ratio Kezar Life Sciences Inc. (KZR)|Short-Term Debt to Equity Ratio SABS (SAB Biotherapeutics, Inc)|Short-Term Debt to Capital Coefficient Akari Therapeutics, Plc|Short-Term Debt to Capital ENLV (Enlivex Therapeutics Ltd.)|Ratio of Short-Term Indebtedness to Capital QTTB|GOVX - Short-Term Debt to Equity|Current Liabilities to Capital Edesa Biotech Inc|iBio Corp (IBIO) - Short-Term Debt to Equity|Current Liabilities to Capital Carisma Therapeutics Inc. (CARM)|Short-Term Debt to Equity XTL Biopharmaceuticals|Short-Term Debt to Capital Bolt Bio|Short-Term Debt to Equity HCW Biologics Inc. (HCWB)|APVO: Current Liabilities to Equity|Short-Term Debt to Capital AIM (AIM ImmunoTech Inc.)|Ratio of Short-Term Indebtedness to Capital ADTX|GRI Bio, Inc. - Short-Term Debt to Capital|XRTX - Short-Term Debt to Capital|Vyome Holdings (HIND) - Short-Term Debt to Equity|Revelation Biosciences Inc - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity Indaptus|Short-Term Debt to Equity Ratio BiondVax Pharmaceuticals (SCNI)|Short-Term Debt to Capital CALI|Short-Term Debt to Capital affimed.com (AFMD)|Allakos - Short-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital IGMS|iTeos - Short-Term Debt to Capital|Short-Term Debt to Capital Coefficient Ocean Biomedical Corp OCEA|TC Biopharm (TCBP) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio thirdharmonicbio.com